Gene Expression Test Aims to Personalize Systemic Therapy for Atopic Dermatitis

Gene Expression Test Aims to Personalize Systemic Therapy for Atopic Dermatitis

A noninvasive molecular test identifies patients more likely to respond to JAK inhibitors versus Th2-targeted therapies, potentially accelerating clearance and reducing treatment switches. A new gene expression test can help clinicians identify patients with moderate-to-severe atopic dermatitis who are more likely to achieve better outcomes with JAK inhibitor therapy compared to Th2-targeted treatments, according to a prospective validation stud…